1-2 of 2
Yo Mabuchi, PhD
Close
Sort by
Journal Articles

Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms

Yoshihiko Kihara, Marito Araki, PhD, Misa Imai, PhD, Yosuke Mori, MD, Mei Horino, Satoko Ogata, PhD, Syunpei Yoshikawa, Teppei Taguchi, Nami Masubuchi, PhD, Yo Mabuchi, PhD, Yinjie Yang, PhD, Yasutaka Fukuda, MDPhD, Soji Morishita, PhD, Takehiro Suzuki, PhD, Naoshi Domae, PhD, Motoyuki Shimonaka, PhD, Chihiro Akazawa, MD PhD, Akimichi Ohsaka, MD PhD, Norio Komatsu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-141159
Published: 2020
Journal Articles

Impaired Osteoblastic Differentiation of MSCs Suppresses Normal Hematopoiesis in MDS

Yasutaka Hayashi, MDPhD, Kimihito Cojin Kawabata, MD PhD, Yosuke Tanaka, PhD, Yasufumi Uehara, MDPhD, Shigeru Kiryu, MD PhD, Yasunori Ota, MD PhD, Yusuke Yoshioka, PhD, Yo Mabuchi, PhD, Tatsuki Sugiyama, MDPhD, Keiko Mikami, MSc, Moe Tamura, MSc, Tsuyoshi Fukushima, MD PhD, Shuhei Asada, MDPhD, Reina Takeda, MDPhD, Yuya Kunisaki, MD PhD, Tomofusa Fukuyama, MD PhD, Susumu Goyama, MD PhD, Kazuaki Yokoyama, MD PhD, Arinobu Tojo, MD PhD, Yoshio Katayama, MD PhD, Fumio Arai, PhD, Takashi Nagasawa, MDPhD, Takahiro Ochiya, PhD, Daichi Inoue, MDPhD, Toshio Kitamura, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-142284
Published: 2020